U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07193563) titled 'ENX-102 Phase 2 Social Anxiety Disorder' on Sept. 24.
Brief Summary: This is a double-blind study to evaluate the efficacy and safety of ENX-102 in participants with social anxiety disorder (SAD).
Study Start Date: Sept. 05
Study Type: INTERVENTIONAL
Condition:
Social Anxiety Disorder (SAD)
Intervention:
DRUG: ENX-102
oral capsule
OTHER: Placebo
oral capsule
Recruitment Status: RECRUITING
Sponsor: Engrail Therapeutics INC
Published by HT Digital Content Services with permission from Health Daily Digest....